TerminatedNot applicableNCT03624608
Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
Studying Microtia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Reconstrata, LLC
- Principal Investigator
- Angelo Leto Barone, DNPReconstrata, LLC
- Intervention
- AuryzoN Family of Devices(device)
- Enrollment
- 2 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2025
Study locations (1)
- Cincinnati Children's Hospital, Cincinnati, Ohio, United States
Collaborators
Children's Hospital Medical Center, Cincinnati
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03624608 on ClinicalTrials.govOther trials for Microtia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06087874Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal JaundiceChinese University of Hong Kong
- ACTIVE NOT RECRUITINGNCT06289283Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in BladderTheodor Bilharz Research Institute
- RECRUITINGPHASE2NCT05288790Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCTVanderbilt University Medical Center